NSEGeneral Updates4d ago · 17 Jul 2026, 10:37 pm
General Updates
Torrent Pharmaceuticals Limited · TORNTPHARM
✦ AI SummaryESG
Torrent Pharmaceuticals Limited has informed the Exchange about General Updates, specifically that Crisil ESG Ratings & Analytics Limited has independently assigned the rating of 'Crisil ESG 66' and the Core ESG rating of 'Crisil Core ESG 74'.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Torrent Pharmaceuticals Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
TORNTPHARM_17072026223743_SEIntimationESGRating1707.pdf
View document text
17th July, 2026
The Dy. General Manager (Listing Dept.) The Manager – Listing Dept.,
BSE Limited., National Stock Exchange of India Ltd.,
Corporate Relationship Dept., Exchange Plaza, 5th Floor,
1st Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai – 400 051
(BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
Pursuant to the provisions of Regulation 30 read with Schedule III of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 and the SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026, we hereby notify that
Crisil ESG Ratings & Analytics Limited, a SEBI registered ESG Rating Provider (“Crisil ESG
Ratings”), has independently assigned the rating of ‘Crisil ESG 66’ and the Core ESG rating of
‘Crisil Core ESG 74’.
Kindly take note of the above.
Thanking you,
Yours Sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI
COMPANY SECRETARY
Email – investorservices@torrentpharma.com